We are live on ! Find out more
CADX

CADENCE PHARMACEUTICALS, INC COM STK
CADX

Delisted

CADX was delisted on the 18th of March, 2014.

Back to rankings

Fund managers haven’t disclosed any holdings of CADX yet.

CADX Hedge Fund Activity: Q2 2014 in Review

0 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in CADENCE PHARMACEUTICALS, INC COM STK (CADX) for Q2 2014, worth a combined $0 — down 100% from $3.77M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CADX and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Omni Partners, exiting entirely with an estimated $3.5M sold.

  • 0 institutional investors held CADENCE PHARMACEUTICALS, INC COM STK (CADX) as of Q2 2014, down from 3 in Q1 2014.
  • Funds reported $0 of CADENCE PHARMACEUTICALS, INC COM STK stock for Q2 2014, down 100% quarter-over-quarter.
  • 0 funds opened new CADENCE PHARMACEUTICALS, INC COM STK positions in Q2 2014 and 3 closed out, a net change of -3 holders.
  • The largest CADENCE PHARMACEUTICALS, INC COM STK seller in Q2 2014 was Omni Partners, an estimated $3.5M sold.

Based on aggregated 13F filings for Q2 2014.